Get access to our best features

Get access to our best features

The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion

Summary by Ground News
The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer’s earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, the company reported Tuesday.
Published 4 months ago · New York, United States

News Articles

More Filters
All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

56% of the sources lean Left
Alternet
Common Dreams
Irish Examiner
El Pais
Politico
CNBC
The Hill
MarketWatch
The Epoch Times
L 56%
C 33%
11%
See less detail